FGFR Inhibitor ET0111 Monotherapy in Patients With Advanced Solid Tumors

NCT05522309 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: ET0111

Sponsor

Etern BioPharma (Shanghai) Co., Ltd